Good evening :)
Switch to
Place Order

Sun Pharma Advanced Research Co Ltd

SPARC
Health CarePharmaceuticals
SmallcapWith a market cap of ₹6,376 cr, stock is ranked 396
Moderate RiskStock is 2.72x as volatile as Nifty
245.652.30 (+0.95%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹6,376 cr, stock is ranked 396
Moderate RiskStock is 2.72x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
-42.19
PB RatioPB Ratio
-342.29
Dividend YieldDiv. Yield
Sector PESector PE
37.32
Sector PBSector PB
5.23
Sector Div YldSctr Div Yld
0.61%

Forecast & RatingsDetailed Forecast 

100%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Sun Pharma Advanced Research Company Limited is engaged in the research and experimental development on natural sciences and engineering (Pharmacy).

Investor PresentationView older 

Sep 10, 2020

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

2018201920202021132.18196.3886.57258.37-196.99-145.42-312.41-151.14
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Shareholders meeting 
Announced OnJun 10, 2021

Pursuant to the requirements of Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, we submit herewith the details of the result of remote e-voting as well as e-voting conducted at the Extra-Ordinary General Meeting (EGM) of Sun Pharma Advanced Research Company Limited held on 8th June, 2021 from 04:00 p.m. to 04:40 p.m. through Video Conferencing ( VC )/ Other Audio Visual Means ( OAVM ) in respect of all the resolutions as set out in the Notice dated 12th May 2021, for your information and dissemination. | Download

Pursuant to the requirements of Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, we submit herewith the details of the result of remote e-voting as well as e-voting conducted at the Extra-Ordinary General Meeting (EGM) of Sun Pharma Advanced Research Company Limited held on 8th June, 2021 from 04:00 p.m. to 04:40 p.m. through Video Conferencing ( VC )/ Other Audio Visual Means ( OAVM ) in respect of all the resolutions as set out in the Notice dated 12th May 2021, for your information and dissemination. | Download

Shareholders meeting 
Announced OnJun 9, 2021

Sun Pharma Advanced Research Company Limited has informed the Exchange regarding Proceedings of Extraordinary General Meeting held on Jun 08, 2021 | Download

Sun Pharma Advanced Research Company Limited has informed the Exchange regarding Proceedings of Extraordinary General Meeting held on Jun 08, 2021 | Download

See all events